Prevalence, characteristics, and mortality outcomes of obese and nonobese MAFLD in the United States

The metabolic profiles and body composition of lean metabolic associated fatty liver disease

(2021) Yu-Ming Cheng et al.   Hepatology International

Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States

(2021) Donghee Kim et al.   JOURNAL OF HEPATOLOGY

Risk factors of nonalcoholic fatty liver disease in lean body mass population: A systematic review and meta‐analysis

(2021) Shahinul Alam et al.   JGH Open

Association Between Fibrosis Stage and Outcomes of Patients with Non-Alcoholic Fatty Liver Disease: a Systematic Review and Meta-Analysis

(2020) Rod S. Taylor et al.   GASTROENTEROLOGY

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Prevalence, characteristics and mortality outcomes of obese, nonobese and lean NAFLD in the United States, 1999–2016

(2020) B. Zou et al.   JOURNAL OF INTERNAL MEDICINE

The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

(2020) Mohammed Eslam et al.   Hepatology International

AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review

(2020) Zobair M. Younossi et al.   GASTROENTEROLOGY

Lean NAFLD : A Distinct Entity Shaped by Differential Metabolic Adaptation

(2019) Fei Chen et al.   HEPATOLOGY

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

(2017) Parambir S. Dulai et al.   HEPATOLOGY

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

(2017) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

Prevalence of non-alcoholic fatty liver disease and risk factors for advanced fibrosis and mortality in the United States

(2017) Michael H. Le et al.   PLoS One

Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver

(2016) Alexandra Feldman et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Body Mass Index and Risk of Nonalcoholic Fatty Liver Disease: Two Electronic Health Record Prospective Studies

(2016) A. Katrina Loomis et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

(2015) Mattias Ekstedt et al.   HEPATOLOGY

NAFLD: A multisystem disease

(2015) Christopher D. Byrne et al.   JOURNAL OF HEPATOLOGY

Independent Association Between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease in the US Population

(2012) Maria Stepanova et al.   Clinical Gastroenterology and Hepatology

Nonalcoholic Fatty Liver Disease in Lean Individuals in the United States

(2012) Zobair M. Younossi et al.   MEDICINE